Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

90
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
90
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

215
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
215
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

101
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
101
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

42
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
42
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

373
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
373
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

130
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
130

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Neuro Behcet's Disease Across North Africa: a Systematic Review and Meta Analysis.

Clinical reviews in allergy & immunology·2026
Same author

Diagnostic and Clinical Challenges of Hantavirus-Associated Acute Kidney Injury.

European journal of case reports in internal medicine·2026
Same author

Correction: Belfeki et al. State of the Art of Cardiac Amyloidosis. <i>Biomedicines</i> 2023, <i>11</i>, 1045.

Biomedicines·2026
Same author

Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.

The journal of allergy and clinical immunology. In practice·2025
Same author

Etiopathogenesis of Behçet's disease: A systematic literature review.

Clinical immunology (Orlando, Fla.)·2025
Same author

Prognosis of essential mixed cryoglobulinemia and connective tissue disease-related cryoglobulinemia after rituximab-induced remission.

Rheumatology (Oxford, England)·2025

Related Experiment Video

Updated: May 20, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

1.8K

Cogan's syndrome. A comprehensive review.

Nabil Belfeki1, Nouha Ghriss1, Sonia Kammoun1

  • 1Department of Internal Medicine and Clinical Immunology. Groupe Hospitalier Sud Ile de France, Melun, France.

European Journal of Internal Medicine
|May 18, 2025
PubMed
Summary

Cogan syndrome (CS) is a rare autoimmune vasculitis impacting the eyes and ears, primarily in young adults. Early diagnosis and intervention are crucial to prevent irreversible hearing and vision loss.

Keywords:
Biological agentsCogan’s syndromeHearing lossInterstitial keratitisPrognosisVasculitis

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.7K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.0K

Related Experiment Videos

Last Updated: May 20, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

1.8K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.7K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.0K

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Otolaryngology

Background:

  • Cogan syndrome (CS) is a rare autoimmune systemic vasculitis.
  • It primarily affects young adults, involving the inner ear and eyes, with potential systemic manifestations.
  • CS is classified into typical and atypical subtypes based on organ involvement and timing.

Purpose of the Study:

  • To review the clinical spectrum and outcomes of Cogan syndrome.
  • To summarize published case series, differential diagnoses, and therapeutic strategies.
  • To highlight recent advancements in biological treatments for CS.

Main Methods:

  • Systematic review of published case series on Cogan syndrome.
  • Analysis of clinical presentations, diagnostic challenges, and treatment outcomes.
  • Focus on differential diagnosis and emerging therapeutic options.

Main Results:

  • Cogan syndrome diagnosis lacks specific criteria or biomarkers, often requiring exclusion of other conditions.
  • Prognosis is linked to the risk of deafness, blindness, and systemic vasculitis complications.
  • Current treatment data is limited, primarily from case reports and series.

Conclusions:

  • Early recognition and intervention in Cogan syndrome are vital to prevent severe, irreversible damage.
  • Treatment remains challenging, necessitating a focus on novel therapeutic strategies.
  • The review emphasizes the need for further research into effective management of CS, particularly with new biological therapies.